Together, these findings uncover a previously unrecognized CYLD-MEK1/2 axis in macrophages that orchestrates hepatic inflammation and identify MEK signaling as a potential therapeutic target for AIH. This evidence concerns the gene MAP2K7 and autoimmune hepatitis.